Lineage Cell Therapeutics conducts sale of shares in OncoCyte Corporation
Lineage Cell Therapeutics announced the pricing of the sale of 4,000,000 shares of common stock of OncoCyte at a price to buyers of $1.66 per share, the closing price as of September 10, 2019. Gross proceeds from the sale were $6.6 million. The sale is expected to close on Sept. 13, 2019. September 11, 2019